Request Deal Involvement

SoftBank Vision Fund 2 and Cormorant Asset Management led a $210m Series B funding round in Umoja Biopharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morrison Foerster

legal advisors

Morrison Foerster

or

Principals

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

DCVC BIO

bidder

DCVC BIO

PRESIGHT CAPITAL

bidder

PRESIGHT CAPITAL

UMOJA BIOPHARMA

target

UMOJA BIOPHARMA

CASDIN CAPITAL

bidder

CASDIN CAPITAL

EMERSON COLLECTIVE LLC

bidder

EMERSON COLLECTIVE LLC

SOFTBANK VISION FUND 2

bidder

SOFTBANK VISION FUND 2

RTW INVESTMENTS

bidder

RTW INVESTMENTS

CAAS CAPITAL MANAGEMENT

bidder

CAAS CAPITAL MANAGEMENT

SVB LEERINK

bidder

SVB LEERINK

MPM CAPITAL

bidder

MPM CAPITAL

QIMING VENTURE PARTNERS

bidder

QIMING VENTURE PARTNERS

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

TEMASEK HOLDINGS LIMITED

bidder

TEMASEK HOLDINGS LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - SoftBank Vision Fund 2 and Cormorant Asset Management led a $210m Series B funding round in Umoja Biopharma.